Global Anesthesia and Respiratory Devices Market, by Product Type (Anesthesia Devices {Anesthesia Monitoring System (Advanced Anesthesia Monitor (Anesthesia Gas Monitor, Depth of Anesthesia Monitors, Standalone Capnography Monitors, and MRI Compatible Anesthesia Monitor) and Basic Anesthesia Monitors), Anesthesia Machines (Portable Anesthesia Machines and Standalone Anesthesia Machines), Anesthesia Workstation, Anesthesia Ventilators, and Anesthesia Disposables and Accessories}) and (Respiratory Devices (Therapeutic Devices (Positive Airway Pressure (PAP) Devices, Inhalers, Humidifiers, Oxygen Concentrators, Reusable Resuscitators, Respiratory Mask, Nitric Oxide Delivery Units, and Others), Monitoring Devices (Pulse Oximeters, Capnographs, and Gas Analyzers), Diagnostic Devices (Spirometer, Peak Flow Meters, Polysomnography Devices, and Others) and Consumables and Accessories (Tracheostomy Tubes, Nasal Cannulas, and Others), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 27,623.8 Mn in 2019 and is expected to increase to US$ 44,241.2 Mn by 2027, witnessing a CAGR of 6.1% over the forecast period (2019-2027) as highlighted in a new report published by Coherent Market Insights.

Manufacturers are engaged in developing new advanced technology-based devices to improve the patient care, diagnosis, and treatment therapy in healthcare, this has led to increase in product launches and approval, which is expected to boost the global anesthesia and respiratory devices market growth. For instance, in January 2015, Shenzhen Mindray Bio-medical Electronics Co. Ltd. received the premarket approval from the U.S. Food and Drug Administration (FDA) for its anesthesia gas machine under regulatory class II devices.

Moreover, in January 2019, Mindray, a leading developer of next-generation medical technologies launched the new A-Series Advantage Anesthesia Delivery platform, providing a modular, state-of-the-art family of anesthesia solutions. Furthermore, in February 2019, Vapotherm, Inc., a medical technology company focused on the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress, launched the next generation of its product the Precision Flow Hi-VNI system.

Moreover, in September 2018, Glaxo Smith Kline received the U.S. FDA approval for its product Trelegy Ellipta for long term treatment and once-daily maintenance treatment of patients suffering from COPD.

Furthermore, in April 2017, Teva Pharmaceuticals launched AirDuo RespiClick inhalation powder and its generic for the treatment of asthma in patients aged 12 years and above.

Companies are also focused on raising fund for developing monitoring respiratory devices so that new technologies can be embedded with devices for better outcomes. For instance, in January 2018, California-based, Spirosure, Inc. a diagnostic and medical device company, raised US$ 15 million in Series C-2 financing for its breath analysis device, according to the company’s statement. The funding round was led by returning investor NGK Spark Plugs Co. Ltd. of Japan, as well as other unnamed investors. The money will be used to fund sales and regulatory processes in Europe, China, and Japan for Spirosure’s lead product, the Fenom PRO Point-of-Care Breath Analyzer.

North America is expected to hold dominant position in global anesthesia and respiratory devices market over the forecast period. This is attributed to presence of major players in the region such as GE Healthcare, Smiths Medical, 3M, and others. These players are focused on technological advancements in developing innovative anesthesia and respiratory devices with an aim to launch them, and to supply these devices to people, and this is expected to drive the global anesthesia and respiratory devices market growth.

Browse 26 Market Data Tables, and 56 Figures spread through 256 Pages and in-depth TOC on Global Anesthesia and Respiratory Devices Market, by Product Type (Anesthesia Devices {Anesthesia Monitoring System (Advanced Anesthesia Monitor (Anesthesia Gas Monitor, Depth of Anesthesia Monitors, Standalone Capnography Monitors, and MRI Compatible Anesthesia Monitor) and Basic Anesthesia Monitors), Anesthesia Machines (Portable Anesthesia Machines and Standalone Anesthesia Machines), Anesthesia Workstation, Anesthesia Ventilators, and Anesthesia Disposables and Accessories}) and (Respiratory Devices (Therapeutic Devices (Positive Airway Pressure (PAP) Devices, Inhalers, Humidifiers, Oxygen Concentrators, Reusable Resuscitators, Respiratory Mask, Nitric Oxide Delivery Units, and Others), Monitoring Devices (Pulse Oximeters, Capnographs, and Gas Analyzers), Diagnostic Devices (Spirometer, Peak Flow Meters, Polysomnography Devices, and Others) and Consumables and Accessories (Tracheostomy Tubes, Nasal Cannulas, and Others), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027

To know the latest trends and insights prevalent in the hearing protection devices market, click the link below:

https://www.coherentmarketinsights.com/market-insight/anesthesia-and-respiratory-devices-market-532

Manufactures are engaged in adopting inorganic strategies such as collaborations and merger and acquisitions to enhance their product portfolio and strengthen their position in market and this is expected to propel the global anesthesia and respiratory devices market growth.  For instance, in October 2016, Philips entered into collaborative agreement with Mast Therapeutics, to supply Philips I-neb Adaptive Aerosol Delivery (AAD) devices and related consumables for nebulized delivery through company’s AIR001- a sodium nitrate solution for intermittent inhalation.

Moreover, in November 2015, Medtronic Plc acquired Aircraft Medical, a Scottish company that makes handheld video laryngoscopes used to intubate patient. The acquisition expanded endotracheal tubes portfolio of Medtronic Plc.

Key takeaways of the global anesthesia and respiratory devices market:

  • The global anesthesia and respiratory devices market is expected to exhibit a CAGR of 6.1% over the forecast period (2019-2027), owing to a frequent product launches and adoption of inorganic strategies such as mergers and acquisitions by key players. For instance, In March 2015, Smiths Medical launched Portex Blue Line Ultra tracheostomy tubes with thin-walled inner cannulae for adult patients in Europe
  • The anesthesia workstations segment from the global anesthesia and respiratory devices market is expected to hold dominant position in global anesthesia and respiratory devices market over the forecast period, owing to increasing demand of such devices in hospitals and ambulatory care at the time of surgical procedures
  • The therapeutic devices segment in respiratory devices in the global anesthesia and respiratory devices market is expected to witness significant growth in global anesthesia and respiratory devices market over the forecast period, owing to increasing incidence of respiratory diseases such as asthma and Chronic obstructive pulmonary disease (COPD).
  • For instance, according to Forum of International Respiratory Societies, in 2013, an estimated 235 million people suffered from asthma, and over 200 million people were affected due to chronic obstructive pulmonary disease (COPD).
  • Hospitals, ambulatory care, and homecare settings are the major end users for the anesthesia and respiratory devices, as these devices play important role in surgeries for monitoring and administration anesthesia coupled with managing respiratory function of patients.
  • Some of the major players involved in the global anesthesia and respiratory devices market include Fisher and Paykel Healthcare, Invacare Corporation, GE Healthcare, Teleflex Incorporated, AstraZeneca Plc, Drägerwerk AG & Co. KGaAwerk AG, Medtronic Plc, Smiths Medical, OSI System, Getinge AB, Becton, Dickinson and Company, ResMed, Inc, Koninklijke Philips N.V., and 3M.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us: